Table 2 Compliance with treatment stratified according to different variables

Global

3684

816

(22.1)

(20.8–23.5)

 Male

988

211

(21.4)

(18.7–24.0)

0.483

 Female

2696

605

(22.4)

(20.8–24.0)

 Under 35

582

85

(14.6)

(11.7–17.5)

<0.001(*)

 35–64

1901

411

(21.6)

(19.7–23.5)

 Over 65

1201

320

(26.6)

(24.1–29.2)

 =<2

826

59

(7.1)

(5.4–8.9)

<0.001(*)

 2–2.6

822

123

(15.0)

(12.5–17.5)

 2.7–4.3

1057

276

(26.1)

(23.4–28.8)

 >4.3

979

358

(36.6)

(33.5–39.6)

 None

1785

351

(19.7)

(17.8–21.5)

<0.001(*)

 Only anxiety

923

194

(21.0)

(18.3–23.7)

 Only depression

704

197

(28.0)

(24.6–31.4)

 Both

272

74

(27.2)

(21.8–32.6)

 Amitriptyline

787

167

(21.2)

(18.3–24.1)

0.479

 Paroxetine

1880

332

(17.7)

(15.9–19.4)

<0.001(*)

 Fluoxetine

1324

323

(24.4)

(22.0–26.8)

0.014(*)

 Citalopram

1363

318

(23.3)

(21.0–25.6)

0.186

 Sertraline

1024

266

(26.0)

(23.2–28.7)

0.001(*)

 Venlafaxine

932

309

(33.2)

(30.1–36.2)

<0.001(*)

 Clomipramine

414

142

(34.3)

(29.6–39.0)

<0.001(*)

 Mirtazapine

492

153

(31.1)

(26.9–35.3)

<0.001(*)

 Trazodone

230

45

(19.6)

(14.3–24.8)

0.33

 Maprotiline

122

44

(36.1)

(27.4–44.8)

<0.001(*)

 Imipramine

42

16

(38.1)

(23.1–53.1)

0.012(*)

 Nortriptyline

25

10

(40.0)

(20.4–59.6)

0.031(*)

 Fluvoxamine

118

39

(33.1)

(24.4–41.7)

0.004(*)